ClinicalTrials.gov
public full text
Public Domain
Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors
This study concerns the creation of a biological collection (blood samples) in patients with Epithelial Ovarian Cancer in in order to describe the immune response with PARP inhibitors.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Ovarian Cancer#872190
- The Clinical Markers for PARP Inhibitors-related Efficacy in Ovarian Cancer#847360
- Characterization of Ovarian Cancer Stem Cell#1007114
- Study Looking at Biomarkers in Ovarian Cancer#813738
- Supplementary file 1_Adverse events associated with targeted therapy and immunotherapy for ovarian cancer: a FAERS pharmacovigilance study.docx#300638
Record · ID 892920
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive